PPD™ CorEvitas™ Psoriasis (PSO) Early Treatment Response Non-Interventional Study
CorEvitas
Summary
This is a 24-week prospective, single-arm cohort, study of patients initiating advanced therapy for the treatment of moderate-to-severe plaque PSO. Eligible patients must be willing to be seen in-person by their treating physician for a Baseline visit (with first dose of the advanced therapy occurring within 14 days), and at 16 (+/- 5 days) and 24 weeks (+14 days) calculated based on date of first dose of the advanced therapy and must provide informed consent prior to enrolling in the study or completing study-specific questionnaires or procedures. Data will be collected from both subjects and their treating dermatology provider at predetermined scheduled intervals (Baseline, Week 16 and Week 24) using a structured and standardized data collection tool.
Description
Data collected through the study may be used to address a range of research questions and use cases and objectives, including but not limited to study * Creation of a cohort of psoriasis subjects to describe the clinical and patient-reported outcomes (PRO) and changes at 16 and 24 weeks after initiation of the advanced therapy. * Inform clinical decision making by subjects and treating providers. This will be enabled through the standardized data collection including validated patient-reported outcomes (PRO) and clinician-reported outcomes (ClinRO), and the recording of medication utilization…
Eligibility
- Age range
- 18+ years
- Sex
- All
- Healthy volunteers
- Yes
Inclusion Criteria: To be eligible to participate in this study, an individual must meet all the following criteria: 1. Patient is at least 18 years of age at the time of study enrollment. 2. Patient has a diagnosis of moderate to severe plaque psoriasis based on an investigator Global Assessment (IGA, score of 3 or 4 at the time of Enrollment). 3. Patient is initiating new Eligible Medication for the first time for the treatment of PSO. 4. Patient is willing and able to provide informed consent to participate in this study. Exclusion Criteria: An individual who meets any of the following…
Interventions
- OtherObservational (Non-Interventional) Registry
This is an observational (non-interventional) registry
Locations (2)
- CorEvitas, LLCWaltham, Massachusetts
- CorEvitas, LLCWaltham, Massachusetts